Phase II Mayo Clinic Stem Cell Trial for HLHS

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The purpose of this research study is to find out if stem cells from umbilical cord blood (collected at birth) can strengthen the muscle of the right side of the heart for patients diagnosed with Hypolplastic Left Heart Syndrome who are scheduled to undergo the Stage II Glenn surgical procedure.

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at shankars1 [at] chop.edu or 267-425-1984.

Eligibility & Criteria

IRB #:
18-015592
Official Title:
Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells during Stage II Surgical Repair of Hypoplastic Left Heart Syndrome (Auto Cell-II)
Study Phase:
Phase II
Eligible Age Range:
0 - 13 Months
Gender:
All
Study Categories:
Leader
Joseph W. Rossano

Joseph W. Rossano, MD